Sanofi’s VEGF Inhibitor Clears MHLW Advisory Panel for Colorectal Cancer

February 6, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on February 3 backed approval for Sanofi’s VEGF inhibitor aflibercept beta for the treatment of colorectal cancer. The drug is already approved in the US and Europe...read more